Immune responses in dengue and sepsis patients
Part of Infections clinical trials.
This study looks at how the immune system responds to dengue fever and sepsis (a severe infection). It aims to better understand these illnesses, which could lead to improved treatments. If you have dengue-like symptoms, sepsis, or are a healthy volunteer, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have dengue-like symptoms (such as fever and headache) for less than 3 days, or be diagnosed with sepsis and on antibiotics, or be a healthy volunteer without recent illness.
- You must be at least 2 years old and not pregnant or breastfeeding.
- You cannot have a serious long-term condition like diabetes, cancer, or HIV.
- You cannot have taken immune-suppressing drugs or NSAIDs (like ibuprofen) for more than 2 weeks in the past 6 months.
- You must be willing to give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how the body responds to a mild, lab-made dengue virus in people who have had dengue before. It looks at how the immune system reacts to a second infection, which may help improve future vaccines and treatments.
This study looks at how the immune system changes in people with sepsis (a severe response to infection that can cause organ failure). It aims to understand immune dysfunction to help improve treatments.
This study tests a controlled dengue infection in people who already have immunity to some types of dengue. It aims to understand how the immune system responds and to help develop better vaccines. You may qualify if you are a healthy adult aged 18-40 and have evidence of prior dengue exposure to certain virus types.
This study tests new medicines for people hospitalized with moderate-to-severe dengue fever. Dengue is a mosquito-borne virus that can cause serious complications like severe bleeding, organ damage, or shock. The trial aims to find treatments that help patients recover faster and avoid life-threatening complications.
This trial tests how the dengue virus affects healthy adults who have never been exposed to dengue or similar viruses. You would be given a controlled dose of the virus and closely monitored to help researchers understand the infection and develop better treatments or vaccines.
This study is looking at how the immune system changes in people with sepsis. If you have been diagnosed with sepsis in the last 48 hours, researchers want to better understand your immune response, which could help improve treatments.
Hear when a new Dengue trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.